Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine

Clinical trial NCT05110417 · UNKNOWN

Trial details

NCT number: NCT05110417
Sponsor: Eastern Virginia Medical School
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Dysphonia, Spastic Dysphonia Laryngeal Dystonia

Start date: 2021-05-20
Primary completion: 2022-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.